HEALTH DISEASE STATUS IN THE BLSA--CLINICAL HEALTH EVALUATION

健康评估是 BLSA被许多研究人员用来描述健康状况， 每个参与者的状态。在所有BLSA参与者上完成 在每次由执业护士和医生助理进行的访问中， 负责管理和/或审查所有问卷的准确性。的 评估包括人口统计调查表;健康 调查个人健康状况的问卷; 药物清单及其使用性质;一般 身体检查，以及女性盆腔检查;以及 制定诊断清单。健康评估还 为一些研究方案提供健康检查。的 该股继续处理筛选和研究方案;提供 为研究人员开展研究提供技术支持 研究;并努力减少和/或预防潜在的不良反应 结果或其他问题。作为我们质量保证的一部分 我们继续评估新健康的价值 BLSA研究问卷。持续的改善使 关于雌激素使用的调查问卷 绝经期和绝经后。调查表已在 过去六年的发展，现在直接进入 电脑系统在面试中继续努力 识别并纠正任何不一致的回应。的答复 已经被几个研究者用来检验 雌激素治疗在认知，肌肉力量，预防 老年痴呆症和唾液腺功能。

The health evaluation is a central component of the BLSA that is used by many investigators to characterize the health status of each participants. It is completed on all BLSA participants at each of their visits by nurse practitioners and physician assistants who administer and/or review all questionnaires for accuracy. The evaluation includes a demographic questionnaire; a health questionnaire that surveys the health status of the individual; a listing of medications and the nature of their usage; a general physical examination, and for the women a pelvic examination; and the development of a diagnostic list. The health evaluation also provides health screening for a number of research protocols. The unit continues to handle screening and research protocols; provided technical support to investigators in the development of research studies; and worked to minimize and/or prevent potential adverse outcomes or other problems. As part of our quality assurance program we continue to assess the value of the new health questionnaire for BLSA research. Continued improvements have been made to our questionnaire regarding the use of estrogen during and following menopause. The questionnaire had been under development for the past six years, and is now entered directly into the computer system during the interview. Efforts continue to identify and correct any response disagreements. The responses have been used by several investigators to examine the value of estrogen treatment in cognition, muscle strength, prevention of Alzheimer's disease, and salivary gland function.